Literature DB >> 12167424

Carcinoma of the parotid and submandibular glands--a study of survival in 2465 patients.

Peter Wahlberg1, H Anderson, A Biörklund, T Möller, R Perfekt.   

Abstract

Salivary gland carcinomas demonstrate a wide diversity of histopathological types and biological behavior. The aim of this study was to analyze relative survival of patients with major salivary gland carcinomas with special reference to histopathology, gender and age. All new carcinomas of the major salivary glands reported to the National Swedish Cancer Registry 1960-1995 were searched for and the vital status of the cases was updated by record linkage to the Swedish Population Registry through December 31 1996. The study comprised 2465 patients with carcinoma of the parotid or submandibular glands. Relative survival differed markedly according to histopathological typing (P<0.001). For parotid tumors, acinic cell carcinomas had the best prognosis with a 10-year relative survival of 88%. The corresponding figures for mucoepidermoid carcinomas, adenoidcystic carcinomas and carcinoma ex pleomorphic adenoma were 80, 74 and 73%. Adenocarcinoma NOS and undifferentiated carcinoma had worse prognosis, with 10-year relative survival of 55 and 44%. Patients with submandibular gland cancer had similar relative survival to those with parotid cancers, besides those with mucoepidermoid cancer and adenocarcinoma NOS, who carried worse prognosis. Age and gender had an impact on relative survival for patients with mucoepidermoid carcinoma, adenocarcinoma and undifferentiated cancer of the parotid.

Entities:  

Mesh:

Year:  2002        PMID: 12167424     DOI: 10.1016/s1368-8375(02)00007-6

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  45 in total

1.  Carcinosarcoma of Submandibular Salivary Gland with a Rare Sarcomatous Variant.

Authors:  Shalini Bhalla; Naseem Akhtar; Puneet Prakash; Malti Kumari; Madhu Mati Goel
Journal:  Indian J Surg Oncol       Date:  2018-10-31

Review 2.  p53 and Cell Fate: Sensitizing Head and Neck Cancer Stem Cells to Chemotherapy.

Authors:  Christie Rodriguez-Ramirez; Jacques E Nör
Journal:  Crit Rev Oncog       Date:  2018

3.  Prognostic value of comorbidities in patients with carcinoma of the major salivary glands.

Authors:  Christoph Becker; Kilian Konrad Kenjiro Dahlem; Jens Pfeiffer
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-25       Impact factor: 2.503

4.  Outcome and management of rare high-grade "salivary" adenocarcinoma: the important role of adjuvant (chemo)radiotherapy.

Authors:  Claudia Scherl; Marlen Haderlein; Abbas Agaimy; Konstantinos Mantsopoulos; Michael Koch; Maximilian Traxdorf; Rainer Fietkau; Philipp Grundtner; Heinrich Iro
Journal:  Strahlenther Onkol       Date:  2019-07-26       Impact factor: 3.621

5.  Acinic cell carcinoma in pregnancy: a case report and review of the literature.

Authors:  Nabil N Al-Zaher; Amani A Obeid
Journal:  J Med Case Rep       Date:  2011-03-04

6.  A case of carcinoma ex pleomorphic adenoma in the buccal mucosa: review of the literature.

Authors:  Shinnosuke Nakamura; Madoka Inui; Yoshihiko Matsumura; Takashi Takeoka; Kenya Okumura; Toshiro Tagawa
Journal:  J Maxillofac Oral Surg       Date:  2011-06-15

7.  Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine.

Authors:  Elad Sharon; Ronan J Kelly; Eva Szabo
Journal:  Head Neck Oncol       Date:  2010-05-26

8.  [Malignant epithelial salivary gland tumors. Clinical review of 2 decades].

Authors:  H Kokemüller; N Brüggemann; P Brachvogel; A Eckardt
Journal:  Mund Kiefer Gesichtschir       Date:  2004-02-07

9.  Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States.

Authors:  Houda Boukheris; Rochelle E Curtis; Charles E Land; Graça M Dores
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-27       Impact factor: 4.254

10.  [Prognostic value of immunohistochemistry in salivary gland cancer].

Authors:  T Ettl; S Schwarz; T Kühnel; P Stockmann; T E Reichert; O Driemel
Journal:  HNO       Date:  2008-02       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.